Search

You searched for "clinic"

2404 results found

Is it NAION… Now what?

3 April 2024 | | EYE - Neuro-ophthalmology
Case presentation We present the case and discussion of a 46-year-old Caucasian male who complained of immediate reduced vision following complicated neck dissection including a total laryngopharyngectomy, free flap reconstruction for a T4N3 squamous cell carcinoma (SCC) of the left...

PACK-crosslinking for infectious keratitis

1 October 2015 | | EYE - Cornea
Corneal cross-linking with riboflavin and UV-A light (CXL) is a technology that has been initially developed to treat corneal ectatic disorders [1]. Its effect in stabilising diseases such as keratoconus was reported in numerous trials with excellent long-term outcomes and...

Immunoglobulin G4-related ophthalmic disease – what is it? (Part 1)

3 February 2023 | | EYE - General
Part 1: Epidemiology, classification, radiology, histopathology and associations (see Part 2 here) In this two-part series, Li Yen Goh reviews IgG4 disease and reminds us of diagnostic challenges faced. Introduction Immunoglobulin G4 (IgG4) disease is a recently recognised idiopathic systemic...

NICE drugs: an update on what’s good to go

1 June 2014 | | EYE - Neuro-ophthalmology, EYE - Vitreo-Retinal
Treatment options recommended by the National Institute for Health and Care Excellence (NICE) must be readily available for use in the NHS of England and Wales. This article provides an overview of recent guidance from NICE and summary advice issued...

Rare eye diseases: progress continues with authorised orphan medicines and breakthrough technologies

1 October 2018 | | EYE - General
An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...

What’s new in glaucoma? Clinical trials drive practice changes, surgical advancements gather pace

1 December 2021 | | EYE - Glaucoma, EYE - General
Rod McNeil reviews the latest developments in the treatment of glaucoma in the UK. Primary open-angle glaucoma (POAG), which accounts for over two-thirds of all glaucoma cases, has an estimated UK prevalence in 2017 of approximately 2% of people over...

Corneal hysteresis: An emerging biomarker in the management of glaucoma

2 October 2025 | | EYE - Cornea
Corneal hysteresis (CH) is gaining recognition as a valuable parameter in the management of glaucoma. Corneal hysteresis is defined as the difference between the inward and outward pressure responses of the cornea during deformation. This measurement reflects the viscoelastic properties...

Corporate M&A pace gathers momentum

1 October 2019 | | EYE - General
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...

Herpes zoster ophthalmicus: a clinician’s perspective

25 January 2023 | | EYE - General
Introduction Herpes zoster, commonly known as shingles, is caused by the reactivation of varicella zoster virus (VZV). The term herpes is derived from a Greek work, herpein, which means ‘creeping’ and the word zoster means a belt or a girdle...

From novice to overnight on-calls: developing an ophthalmology bootcamp to ease the learning curve for new trainees

4 December 2023 | | EYE - General
Introduction My first ophthalmology on-call was nine years ago and it was a fairly traumatic experience. I was an FY2 in a Welsh district general hospital and I was on my own – at least, that’s how it felt to...

Eye News Bring Artistic Eye to RCOphth

29 April 2022
Eye News is delighted to be taking some of Steve Thomson's artwork to the RCOphth in May, raising money for the charity Fight for Sight.

Mind the gap

4 February 2025 |
As a medical student in London many moons ago, the only thing that I was mindful of was the gap between the platform and the train as I traversed the city on the underground. I first became aware of mindfulness...